CYTH

Cyclo Therapeutics (CYTH)

Cyclo Therapeutics Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:CYTH

1 2 3 4 5 6 7 8 9 10 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2025/02/07	22:05	Business Wire	Cyclo Therapeutics Presents Positive Preliminary Data from Ongoing Phase 3 TransportNPC™ Open-Label Sub-Study in Patients (< 3 Years Old)	NASDAQ:CYTH	Cyclo Therapeutics Inc
2025/01/14	22:05	Business Wire	Cyclo Therapeutics to Present at the 21st Annual WORLDSymposium™ 2025	NASDAQ:CYTH	Cyclo Therapeutics Inc
2024/12/11	21:00	GlobeNewswire Inc.	Rafael Holdings Reports First Quarter Fiscal 2025 Financial Results	NASDAQ:CYTH	Cyclo Therapeutics Inc
2024/11/14	22:05	Business Wire	Cyclo Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update	NASDAQ:CYTH	Cyclo Therapeutics Inc
2024/11/07	09:14	GlobeNewswire Inc.	Rafael Holdings Reports Fourth Quarter and Full Year Fiscal 2024 Financial Results	NASDAQ:CYTH	Cyclo Therapeutics Inc
2024/10/21	21:00	GlobeNewswire Inc.	Pacira BioSciences Appoints Shawn Cross as Chief Financial Officer	NASDAQ:CYTH	Cyclo Therapeutics Inc
2024/09/05	22:05	Business Wire	Cyclo Therapeutics Presents Encouraging Preliminary Safety Data from Ongoing Pivotal Phase 3 Study and Substudy for the Treatment of Niemann-Pick Disease Type C1 (NPC1)	NASDAQ:CYTH	Cyclo Therapeutics Inc
2024/08/26	22:37	PR Newswire (US)	Kuehn Law Encourages CYTH, ARCH, CEIX, and VGR Investors to Contact Law Firm	NASDAQ:CYTH	Cyclo Therapeutics Inc
2024/08/22	22:37	Edgar (US Regulatory)	Form 425 - Prospectuses and communications, business combinations	NASDAQ:CYTH	Cyclo Therapeutics Inc
2024/08/22	22:36	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:CYTH	Cyclo Therapeutics Inc
2024/08/22	19:50	GlobeNewswire Inc.	Rafael Holdings and Cyclo Therapeutics Enter into a Definitive Merger Agreement	NASDAQ:CYTH	Cyclo Therapeutics Inc
2024/08/22	19:50	Business Wire	Rafael Holdings and Cyclo Therapeutics Enter Into a Definitive Merger Agreement	NASDAQ:CYTH	Cyclo Therapeutics Inc
2024/08/21	02:50	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:CYTH	Cyclo Therapeutics Inc
2024/08/21	02:49	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:CYTH	Cyclo Therapeutics Inc
2024/08/21	02:49	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:CYTH	Cyclo Therapeutics Inc
2024/08/21	02:49	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:CYTH	Cyclo Therapeutics Inc
2024/08/21	02:48	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:CYTH	Cyclo Therapeutics Inc
2024/08/21	02:48	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:CYTH	Cyclo Therapeutics Inc
2024/08/21	02:47	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:CYTH	Cyclo Therapeutics Inc
2024/08/15	22:00	Business Wire	Cyclo Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update	NASDAQ:CYTH	Cyclo Therapeutics Inc
2024/08/15	06:28	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:CYTH	Cyclo Therapeutics Inc
2024/07/29	22:05	Business Wire	Cyclo Therapeutics Announces Notice of Decision to Grant European Patent Application for Treatment of Alzheimer’s Disease from European Patent Office	NASDAQ:CYTH	Cyclo Therapeutics Inc
2024/07/18	03:35	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:CYTH	Cyclo Therapeutics Inc
2024/06/25	22:25	Business Wire	Cyclo Therapeutics to Present at the Society for the Study of Inborn Errors of Metabolism (SSIEM) Annual Symposium 2024	NASDAQ:CYTH	Cyclo Therapeutics Inc
2024/06/15	05:01	GlobeNewswire Inc.	Rafael Holdings Reports Third Quarter Fiscal 2024 Financial Results	NASDAQ:CYTH	Cyclo Therapeutics Inc
2024/05/30	22:00	Business Wire	Cyclo Therapeutics Achieves Landmark Milestone with Completion of Enrollment of Last Patient in Phase 3 Pivotal TransportNPC™ Trial of Niemann-Pick Type C1	NASDAQ:CYTH	Cyclo Therapeutics Inc
2024/05/16	21:05	Business Wire	Cyclo Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update	NASDAQ:CYTH	Cyclo Therapeutics Inc
2024/03/18	22:05	Business Wire	Cyclo Therapeutics Reports Full Year 2023 Financial Results and Provides Business Update	NASDAQ:CYTH	Cyclo Therapeutics Inc
2024/03/14	22:34	Business Wire	Cyclo Therapeutics Announces Issuance of U.S. Patent Covering the Use of Trappsol® Cyclo™ for the Treatment of Alzheimer’s Disease	NASDAQ:CYTH	Cyclo Therapeutics Inc
2024/03/14	06:04	GlobeNewswire Inc.	Rafael Holdings Reports Second Quarter Fiscal 2024 Financial Results	NASDAQ:CYTH	Cyclo Therapeutics Inc